Author + information
- Nihan Kahya Eren1,
- Ali Hikmet Kırdök2,
- Uğur Kocabaş1,
- Barış Düzel1,
- Rida Berilgen3,
- Cem Nazlı1 and
- Oktay Ergene4
Quality of life has become an important outcome measure in addition to mortality and morbidity in patients with congenital heart disease. Atrial septal defect (ASD) is a common congenital heart disease and transcatheter ASD closure has become an accepted treatment modality. The aim of this study is to assess the quality of life of ASD patients who underwent percutaneous closure.
We examined the quality of life of 69 ASD patients and 69 healthy controls matched according to age, sex, educational level, economic, marital and employment status (1:1 matching). Quality of life was investigated by the Turkish version of Short Form-36 (SF-36).
The mean age of the patients was 39.7±14.2 and 26% were male. The quality of life assessment was performed at a mean follow-up time of 18.0±13.8 months after the intervention. Thirty one percent of the patients reported atypical chest pain, 16% reported palpitations and 11% reported shortness of breath at the time of quality of life assessment. Patients who had palpitations were further investigated with holter monitoring and no serious arrhythmia was detected. The mean scores of the domains of the SF-36 namely, physical functioning, role functioning, social functioning, mental health, vitality, pain and general health were similar in ASD patients and the control group (Table 1). The only sociodemographic variable that was found to be associated with quality of life outcome parameters in the patient group was educational level. Higher educational level was significantly associated with better mental health and better general health perception (r=0.248, p=0.04; r=0.315, p=0.008, respectively).
Adult patients who underwent percutaneous ASD closure perceive their quality of life as good as their healty counterparts.
|ASD patiens||Control group||p value|
The SF-36 domain scores in ASD patients and the control group.